We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.
We also want to provide a shareholder return that reflects outstanding performance and to adequately reward those who invest ideas and work in our company.
We believe our portfolio best meets the varied and often complex needs of patients and societies. Novartis is positioned to lead in innovation, partner with others and offer solutions to patients across a broad healthcare spectrum. In addition, a diverse portfolio reduces financial risk, bringing greater value to those who invest in our company. Our unique portfolio focuses on science-based healthcare sectors that are growing rapidly, reward innovation, and enhance the lives of patients. Novartis is the only company with leading positions in each of these key areas:
Products and Services
Pharmaceuticals: innovative patent-protected medicines
Alcon: global leader in eye care with surgical, ophthalmology and consumer products
Sandoz: affordable, high-quality generic medicines and biosimilars
Consumer Health: self-medication products and treatments for animals
Vaccines and Diagnostics: vaccines and diagnostic tools to protect against life-threatening diseases
Since Novartis was created in 1996 – when only 45% of net sales came from healthcare – the company has shifted focus to fast-growing areas of healthcare.
Novartis Healthcare A/S
Edvard Thomsensvej 14, 3. sal
2300 København S
45 39 16 84 00